Deutetrabenazine News
Deutetrabenazine currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Deutetrabenazine with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Treatment of moderate to severe tardive dyskinesia in adults.
- Evidence level: L5
- Predicted indications (20):
- psychogenic movement disorders (98.7%)
- tremor-nystagmus-duodenal ulcer syndrome (98.7%)
- primary orthostatic tremor (98.7%)
- benign paroxysmal tonic upgaze of childhood with ataxia (98.6%)
- chronic tic disorder (98.3%)
- extrapyramidal and movement disease (98.3%)
- benign shuddering attacks (98.3%)
- polycystic kidney disease 3 with or without polycystic liver disease (97.9%)
- acute intermittent porphyria (97.7%)
- Hirschsprung disease (97.6%)
- lingual-facial-buccal dyskinesia (97.4%)
- renal-hepatic-pancreatic dysplasia (97.2%)
- miscellaneous movement disorder due to neurodegenerative disease (97.2%)
- karyomegalic interstitial nephritis (97.0%)
- Joubert syndrome with renal defect (96.8%)
- thoracic malformation (96.6%)
- adult familial nephronophthisis-spastic quadriparesia syndrome (96.5%)
- Huntington disease-like syndrome due to C9ORF72 expansions (95.6%)
- juvenile Huntington disease (95.0%)
- glutaric acidemia type 3 (94.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.